Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease

Seizure

Volumn 19, Issue 9, 2010, Pages 602-604

  Benbir, Gulcin ^a   Gunduz, Aysegul ^a   Ertan, Sibel ^a   Ozkara, Cigdem ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hypocupremia; Status epilepticus; Wilson's disease

Indexed keywords

COPPER; DIAZEPAM; ETIRACETAM; PENICILLAMINE; PHENYTOIN; VITAMIN B GROUP; ZINC;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHELATION; DIET; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; HUMAN; HYPOCUPREMIA; LABORATORY TEST; MALE; METABOLIC ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; WILSON DISEASE;

BRAIN; COPPER; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PENICILLAMINE; YOUNG ADULT;

EID: 77957980544     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.07.018     Document Type: Article

References (8)

1. U. Turk-Boru, A. Kocer, R. Alp, M. Gumus, and M. Gumus Status epilepticus in a case with Wilson's disease during d-penicillamine treatment Swiss Medical Weekly 133 2003 446 447
2. T.R. Dening, G.E. Berrios, and J.M. Wlashe Wilson's disease and epilepsy Brain 111 1988 1139 1155
3. K. Gibbs, and J.M. Walshe Penicillamine and pyridoxine requirements in man The Lancet 1 1966 175 179
4. +2 on the membrane ATPase and its relation to initiation of convulsions The Journal of Physiology 181 1965 27 28
5. L.W. Duchen, and J.M. Jacobs Nutritional deficiencies and metabolic disorders J.H. Adams, L.W. Duchen, Greensfield's neuropathology 1994 Edward Arnold London 813 820
6. S.K. Narayan, and N. Kaveer CNS demyelination due to hypocupremia in Wilson's disease from overzealous treatment Neurology India 54 2006 110 111
7. H. Swayback Copper deficiency myelopathy Mayo Clinic Proceedings 81 2006 1371 1384
8. S.R. Sheela, M. Latha, P. Liu, K. Lem, and S.G. Kaler Copper-replacement treatment for symptomatic Menkes disease: ethical considerations Clinical Genetics 68 2005 278 283